{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:26:30Z","timestamp":1780385190200,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jaip.2013.09.019","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T18:32:43Z","timestamp":1388687563000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis"],"prefix":"10.1016","volume":"2","author":[{"given":"William E.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailen","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ullrich","family":"Munzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2013.09.019_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.06.008","article-title":"Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device","volume":"105","author":"Hampel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000351404","article-title":"Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis","volume":"161","author":"Meltzer","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2012.01.077","article-title":"A\u00a0novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis","volume":"129","author":"Carr","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2500\/aap.2012.33.3587","article-title":"MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2013.09.019_bib5","unstructured":"International Committee on Harmonization Harmonized Tripartite Guidelines on Good Clinical Practice (1996). Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf. Accessed June 17, 2011."},{"key":"10.1016\/j.jaip.2013.09.019_bib6","unstructured":"Medical Dictionary for Regulatory Affairs (MedDRA). Version 11.1. Maintenance and Support Services Organization (MSSO). Available from: www.meddra.org."},{"key":"10.1016\/j.jaip.2013.09.019_bib7","unstructured":"International Committee on Harmonization Harmonized Tripartite Guideline. The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions E1(1994). Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E1\/Step4\/E1_Guideline.pdf. Accessed February 22, 2012."},{"key":"10.1016\/j.jaip.2013.09.019_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bjo.81.10.896","article-title":"Cataract progression in India","volume":"81","author":"Srinivasan","year":"1997","journal-title":"Br\u00a0J Ophthalmol"},{"key":"10.1016\/j.jaip.2013.09.019_bib9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1185\/03007995.2010.487661","article-title":"Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis","volume":"26","author":"Baena-Cagnani","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2013.09.019_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2007.01521.x","article-title":"Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis","volume":"62","author":"Rosenblut","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2013.09.019_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2273.1998.00096.x","article-title":"A\u00a01-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study","volume":"23","author":"Holm","year":"1998","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"Suppl","key":"10.1016\/j.jaip.2013.09.019_bib12","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1067\/mai.2000.110038","article-title":"Systemic effects of intranasal steroids: an endocrinologist's perspective","volume":"106","author":"Allen","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0091-6749(03)01870-0","article-title":"Potential adverse effects of the inhaled corticosteroids","volume":"112","author":"Kelly","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib14","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1067\/mai.2001.115564","article-title":"Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children","volume":"108","author":"Boner","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.09.019_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000216193","article-title":"Intranasal corticosteroids and adrenal suppression","volume":"16","author":"Bruni","year":"2009","journal-title":"Neuroimmunomodulation"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981300439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981300439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:05:52Z","timestamp":1761973552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981300439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S221321981300439X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2013.09.019","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2013.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}